Literature DB >> 30418539

Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.

Bastiaan W Haak1, Jacqueline M Lankelma1, Floor Hugenholtz1, Clara Belzer2, Willem M de Vos3, W Joost Wiersinga1,4.   

Abstract

OBJECTIVES: The impact of combination antibiotic therapy on the composition of the intestinal microbiota remains ill-defined. We aimed to assess the effect of a 1 week antibiotic regimen on the intestinal microbiota of healthy humans for a period of up to 31 months. PATIENTS AND METHODS: Thirteen healthy adult men received either no treatment or oral broad-spectrum antibiotics (ciprofloxacin, vancomycin and metronidazole) for 7 days. At four timepoints (prior to treatment, on day 9, day 49 and 8-31 months later) faecal samples were collected and analysed using 16S RNA gene sequencing.
RESULTS: The short-term impact of broad-spectrum antibiotics on the gut microbiota was profound, with a loss of diversity and drastic shifts in community composition. In addition, antibiotics significantly reduced the abundance of bacterial taxa with important metabolic functions, such as the production of butyrate. The microbiota showed a remarkable return towards baseline after 8-31 months, but community composition often remained altered from its initial state.
CONCLUSIONS: These findings suggest that combined treatment with vancomycin, ciprofloxacin and metronidazole has a profound and long-lasting effect on microbiota composition, the consequences of which remain largely unknown.
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30418539     DOI: 10.1093/jac/dky471

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  28 in total

1.  The Role of Microbiota in Preventing Multidrug-Resistant Bacterial Infections.

Authors:  Yascha Khodamoradi; Johanna Kessel; Jörg Janne Vehreschild; Maria J G T Vehreschild
Journal:  Dtsch Arztebl Int       Date:  2019-10-04       Impact factor: 5.594

Review 2.  Can the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?

Authors:  John C Alverdy; Robert Keskey; Renee Thewissen
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

Review 3.  Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches.

Authors:  Priyankar Dey; Saumya Ray Chaudhuri
Journal:  Biology (Basel)       Date:  2022-05-16

Review 4.  Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission.

Authors:  Adam Shute; Dominique G Bihan; Ian A Lewis; Yasmin Nasser
Journal:  Front Neurosci       Date:  2022-06-23       Impact factor: 5.152

5.  Dynamic modulation of spleen germinal center reactions by gut bacteria during Plasmodium infection.

Authors:  Rabindra K Mandal; Joshua E Denny; Ruth Namazzi; Robert O Opoka; Dibyadyuti Datta; Chandy C John; Nathan W Schmidt
Journal:  Cell Rep       Date:  2021-05-11       Impact factor: 9.423

6.  Effects of Vancomycin on Persistent Pain-Stimulated and Pain-Depressed Behaviors in Female Fischer Rats With or Without Voluntary Access to Running Wheels.

Authors:  Emily Payne; Kylee Harrington; Philomena Richard; Rebecca Brackin; Ravin Davis; Sarah Couture; Jacob Liff; Francesca Asmus; Elizabeth Mutina; Anyssa Fisher; Denise Giuvelis; Sebastien Sannajust; Bahman Rostama; Tamara King; Lisa M Mattei; Jung-Jin Lee; Elliot S Friedman; Kyle Bittinger; Meghan May; Glenn W Stevenson
Journal:  J Pain       Date:  2021-05-21       Impact factor: 5.820

Review 7.  Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota.

Authors:  Anna E Lindell; Maria Zimmermann-Kogadeeva; Kiran R Patil
Journal:  Nat Rev Microbiol       Date:  2022-01-31       Impact factor: 78.297

8.  Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic.

Authors:  Ken F Blount; William D Shannon; Elena Deych; Courtney Jones
Journal:  Open Forum Infect Dis       Date:  2019-04-11       Impact factor: 3.835

9.  Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.

Authors:  Jonathan D Cogen; Anna V Faino; Frankline Onchiri; Lucas R Hoffman; Matthew P Kronman; David P Nichols; Margaret Rosenfeld; Ronald L Gibson
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

10.  Dysbiosis of intestinal microbiota in early life aggravates high-fat diet induced dysmetabolism in adult mice.

Authors:  Z H Miao; W X Zhou; R Y Cheng; H J Liang; F L Jiang; X Shen; J H Lu; M Li; F He
Journal:  BMC Microbiol       Date:  2021-07-08       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.